Dyslipidemia: Management Approaches

Start dietary and lifestyle changes
Add lipid-lowering agents (statins, fibrates)
Modify antiretroviral therapy:
- Substitute NNRTIs for PIs
- Substitute abacavir for PIs

Dube MP et al. Clin Infect Dis. 2000;31:1216-24.

• As in patients with high triglycerides, those with hypercholesterolemia should start with dietary and lifestyle changes, such as smoking cessation, weight loss, and limiting alcohol intake.1

• If these measures do not produce the desired results, lipid-lowering agents, such as statins or fibrates, can be added.

• Adjustments in the patient’s antiretroviral therapy regimen should also be considered, particularly if the patient is currently receiving a PI-based regimen. A non-nucleoside agent, such as efavirenz, can be substituted for the PI component. An alternative option is to substitute the PI with abacavir.

Reference:

1. Dube MP, Sprecher D, Henry WK et al. Preliminary guidelines for the evaluation and management of dyslipidemia in HIV-infected adults receiving antiretroviral therapy. Recommendations of the adult ACTG cardiovascular disease focus group. Clin Infect Dis. 2000;31:1216-24.


 

HIV AND AIDS
| HEPATITIS B | HEPATITIS C | HIV / HBV CO-INFECTION | HIV / HCV CO-INFECTION | HEALTH AND TECHNOLOGY | TESTS | INTERNET CONFERENCE REPORTS | TELECONFERENCES | LINKS | ABOUT US | CONTACT US